InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Morosini Deborah, Directeur Exécutif des Affaires Cliniques. Insider active across 1 company, notably Prelude Therapeutics Inc. In total, 2 filings have been recorded. Activity tracked since 16 November 2021. The latest transaction was disclosed on 15 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Morosini Deborah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,016 shares@ US$1.891.5% of flowCommon StockSEC:0001209191-21-070352:0
28,751 shares@ US$12.8598.5% of flowCommon StockSEC:0001209191-21-065616:0
2 of 2 declarations
About Morosini Deborah
Deborah Morosini is the Executive Vice President of Clinical Affairs at Prelude Therapeutics Inc. She oversees the company's clinical initiatives, contributing to innovation and healthcare improvement.
